Bioscience

Small business grant will help develop Valley Fever drug here

May 10, 2010

By Flinn Foundation

[Source: KVOA.com] – A small business grant will help an Arizona-based company develop a drug for Valley Fever.

Valley Fever Solutions Inc (VFS) has been awarded $3 million from the National Institutes for Health (NIH) to continue the commercialization of nikkomycin Z (NikZ), a potentially curative therapy for Valley Fever.

Starting this week, the funds will be administered over the next three-years by the National Center for Minority Health and Health Disparities, one of the institutes and centers of the NIH.

For more information: Small business grant will help develop Valley Fever drug here